Skip to main content
. 2017 Aug 31;8(44):78208–78224. doi: 10.18632/oncotarget.20596

Table 7. Registered clinical studies using nanoprticles in peritoneal carcinoma.

Conditions Intervention Enrollment Phase Number
Fallopian tube carcinoma Primaryperitonealcarcinoma Recurrent ovarian carcinoma Nab-PTX 51 II NCT00499252
Peritoneal carcinoma Nanotax 22 I NCT00666991
Ovarian cancer Peritoneal cavity cancer Nab-PTX 27 I NCT00825201